Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study

Dinh TS, Brueckle M-S, Gonzalez-Gonzalez AI, Witte J, van den Akker M, Gerlach FM, Muth C (2022)
Journal of Personalized Medicine 12(7): 1115.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 1.62 MB
Autor*in
Dinh, Truc Sophia; Brueckle, Maria-Sophie; Gonzalez-Gonzalez, Ana Isabel; Witte, JulianUniBi; van den Akker, Marjan; Gerlach, Ferdinand M; Muth, ChristianeUniBi
Abstract / Bemerkung
Structured management programs have been developed for single diseases but rarely for patients with multiple medications. We conducted a qualitative study to investigate the views of stakeholders on the development and implementation of a polypharmacy management program in Germany. Overall, we interviewed ten experts in the fields of health policy and clinical practice. Using content analysis, we identified inclusion criteria for the selection of suitable patients, the individual elements that should make up such a program, healthcare providers and stakeholders that should be involved, and factors that may support or hinder the program's implementation. All stakeholders were well aware of polypharmacy-related risks and challenges, as well as the urgent need for change. Intervention strategies should address all levels of care and include all concerned patients, caregivers, healthcare providers and stakeholders, and involved parties should agree on a joint approach.
Erscheinungsjahr
2022
Zeitschriftentitel
Journal of Personalized Medicine
Band
12
Ausgabe
7
Art.-Nr.
1115
eISSN
2075-4426
Page URI
https://pub.uni-bielefeld.de/record/2964762

Zitieren

Dinh TS, Brueckle M-S, Gonzalez-Gonzalez AI, et al. Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine . 2022;12(7): 1115.
Dinh, T. S., Brueckle, M. - S., Gonzalez-Gonzalez, A. I., Witte, J., van den Akker, M., Gerlach, F. M., & Muth, C. (2022). Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine , 12(7), 1115. https://doi.org/10.3390/jpm12071115
Dinh, T. S., Brueckle, M. - S., Gonzalez-Gonzalez, A. I., Witte, J., van den Akker, M., Gerlach, F. M., and Muth, C. (2022). Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine 12:1115.
Dinh, T.S., et al., 2022. Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine , 12(7): 1115.
T.S. Dinh, et al., “Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study”, Journal of Personalized Medicine , vol. 12, 2022, : 1115.
Dinh, T.S., Brueckle, M.-S., Gonzalez-Gonzalez, A.I., Witte, J., van den Akker, M., Gerlach, F.M., Muth, C.: Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study. Journal of Personalized Medicine . 12, : 1115 (2022).
Dinh, Truc Sophia, Brueckle, Maria-Sophie, Gonzalez-Gonzalez, Ana Isabel, Witte, Julian, van den Akker, Marjan, Gerlach, Ferdinand M, and Muth, Christiane. “Stakeholder Perspectives on the Development and Implementation of a Polypharmacy Management Program in Germany: Results of a Qualitative Study”. Journal of Personalized Medicine 12.7 (2022): 1115.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2022-08-09T12:47:23Z
MD5 Prüfsumme
83913cd5e24510670909439cedf1b986

Link(s) zu Volltext(en)
Access Level
OA Open Access

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 35887612
PubMed | Europe PMC

Suchen in

Google Scholar